T1	Participants 888 917	279 clinically eligible cases
T3	Participants 199 233	acute promyelocytic leukemia (APL)
#2	AnnotatorNotes T3	Participants had this condition.
T2	Participants 724 733	adult APL
T4	Participants 2419 2431	APL patients
